fashion -WSS

fashion

author：focus 2025-10-01 18:44:23 - browse：5

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Unicorn down: Following layoffs, Biofourmis CEO quietly departs

WSS

NYU Langone launches private ChatGPT for its health care data

Global cancer cases to surge 77% by 2050, WHO report says

Unique patient identifier: Experts argue the benefits, pitfalls

Gene therapy for Afghan refugees’ infant will be fully covered

Adopting new red light myopia treatments may be short

Neuroscience startup Neumora files for IPO

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cano Health’s bankruptcy is a warning for Medicare Advantage

Tori Bowie and the unacceptable rates of Black maternal death

Apellis safety probe of eye disease drug centers on injection needle

New air purifier tech could be key to improving indoor air quality

A protest over insulin prices is seen as a fight for life

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What’s missing from the debate over nursing home staff minimums

Wildfire smoke exposes gaps in outdoor worker protections

2024 GOP presidential candidates spar over abortion in debate

focus

The Biogen Aduhelm mess could happen again

Surgery pushed Ben Carson to fame

FDA panel gives mixed vote on blood pressure devices

The CDC's new social media misinformation war

CDC advisory panel says seniors 'may' get RSV vaccine

Psilocybin's anti

hotspot

hotspot

entertainment

hotspot